Biología molecular del cáncer
University of South Carolina
Columbia, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of South Carolina (1)
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1